Filter results
You can narrow down the results using the filters
Audience
Publication type
Topics
Our work
Diseases
8965 results
-
ATAGI advice on use of sedation for COVID-19 vaccination
Ongoing review of current and emerging evidence, advice on use of sedation. -
Handling procedure for complaints of alleged breaches of the MAIF Agreement – Flowchart
Handling procedure for complaints of alleged breaches of the Marketing in Australia of Infant Formulas: Manufacturers and Importers (MAIF) Agreement -
National Notifiable Diseases Surveillance System (NNDSS) fortnightly reports – 14 to 27 March 2022
This report, and accompanying table, provide a fortnightly summary on notifications of Australia's nationally notifiable diseases for 14 to 27 March 2022. -
Coronavirus (COVID-19) common operating picture – 5 April 2022
This infographic issued on5 April 2022 provides a weekly traffic light report of the coronavirus (COVID-19) situation across Australia. -
Coronavirus (COVID-19) at a glance – 4 April 2022
This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 4 April 2022. -
Coronavirus (COVID-19) at a glance – 5 April 2022
This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 5 April 2022. -
Advisory Committee for the COVID-19 Response for People with Disability – Summary of outcomes 29 March 2022
We provided updates on the COVID-19 vaccination rollout for people with disability and disability support workers. -
COVID-19 vaccination – Disability provider alert 4 April 2022
This alert contains updates for disability service providers about the COVID-19 vaccination rollout. -
All of governments' response to the National Dust Disease Taskforce final report
This document from the Australian and state and territory governments outlines their commitment to reducing incidences of silicosis and other dust diseases among workers, and increase the quality of life for people affected and their families. -
Coronavirus (COVID-19) at a glance – 2 April 2022
This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 2 April 2022. -
Coronavirus (COVID-19) at a glance – 3 April 2022
This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 3 April 2022. -
Coronavirus (COVID-19) at a glance – 1 April 2022
This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 1 April 2022. -
COVID-19 vaccination – print ad – Boost (airport)
This print ad encourages eligible Australians to stay up to date with their vaccination status by booking a COVID-19 booster. -
NPSC communique – 3 March 2022
The third meeting of the Nurse Practitioner Steering Committee (NPSC) was held on 3 March 2022. -
Certification statement – Accessing health care campaign (Phase 1) – television, digital and social
This certification statement, signed by Secretary Brendan Murphy on 31 March 2022, certifies that the Accessing health care campaign complies with relevant guidelines and policies. -
The brilliant women leading MRFF projects
To celebrate our first gender data report on MRFF funding, we present some of the brilliant female Chief Investigators leading MRFF projects. -
COVID-19 vaccination – Local Government Area (LGA) – 4 April 2022
This report lists the percentage of people who have been vaccinated against COVID-19, by Local Government Area. The percentages are further broken down by geographic regions and whether they've had one dose or are fully vaccinated. -
Guidance document for interpretation of the MAIF Agreement – Information and education (clause 4)
This Marketing in Australia of Infant Formulas (MAIF) Agreement Complaints Committee guidance document aims to help interpret clause 4 of the MAIF Agreement, which relates to information and education. -
Guidance document for interpretation of the MAIF Agreement – Scientific and factual information provided to healthcare professionals (clause 7a)
This Marketing in Australia of Infant Formulas (MAIF) Agreement Complaints Committee guidance document aims to help interpret clause 7a of the MAIF Agreement, which relates to scientific and factual information provided to healthcare professionals. -
Guidance document for interpretation of the MAIF Agreement – general public and parents and or carers (clause 5a)
This Marketing in Australia of Infant Formulas (MAIF) Agreement Complaints Committee guidance document aims to help interpret clause 5a of the MAIF Agreement, which relates to the general public, parents and carers. -
Guidance document for interpretation of the MAIF Agreement – Electronic media
This Marketing in Australia of Infant Formulas (MAIF) Agreement Complaints Committee guidance document aims to help interpret information related to electronic media in the MAIF Agreement. -
Care for your health – Your guide to electronic prescribing
This fact sheet outlines accessing medicines through electronic prescriptions. -
Care for your health – Your guide to digital mental health services
This fact sheet, part of the 'Care for your health' campaign, outlines information about mental health services in Australia. -
Human growth hormone (somatropin) approved by the Therapeutic Goods Administration and on the Pharmaceutical Benefits Scheme
This document lists the brand names and sponsor companies for human growth hormone (somatropin) brands that have been approved by the Therapeutic Goods Administration and are subsidised under the Pharmaceutical Benefits Scheme. -
Evaluation of National Psychosocial Support Programs: Final Report
The independent evaluation of the National Psychosocial Support Measure (NPS-M) and Continuity of Support (CoS) program assessed how appropriate, effective, efficient and impactful the programs have been.